140 related articles for article (PubMed ID: 27536444)
1. In vitro evaluation of the effects of 4-aminopyridine on cytochrome P450 enzymes.
Caggiano A; Blight A
J Drug Assess; 2013; 2(1):106-16. PubMed ID: 27536444
[TBL] [Abstract][Full Text] [Related]
2. ZY12201, A Potent TGR5 Agonist: Identification of a Novel Pan CYP450 Inhibitor Tool Compound for In-Vitro Assessment.
Giri P; Gupta L; Rathod A; Joshi V; Giri S; Patel N; Agarwal S; R Jain M
Drug Metab Lett; 2022 Mar; ():. PubMed ID: 35293300
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
[TBL] [Abstract][Full Text] [Related]
4. Identification of metabolites of dalfampridine (4-aminopyridine) in human subjects and reaction phenotyping of relevant cytochrome P450 pathways.
Caggiano A; Blight A
J Drug Assess; 2013; 2(1):117-26. PubMed ID: 27536445
[TBL] [Abstract][Full Text] [Related]
5. In vitro oxidative metabolism of cajaninstilbene Acid by human liver microsomes and hepatocytes: involvement of cytochrome p450 reaction phenotyping, inhibition, and induction studies.
Hua X; Peng X; Tan S; Li C; Wang W; Luo M; Fu Y; Zu Y; Smyth H
J Agric Food Chem; 2014 Oct; 62(43):10604-14. PubMed ID: 25272989
[TBL] [Abstract][Full Text] [Related]
6. In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil.
Robertson P; DeCory HH; Madan A; Parkinson A
Drug Metab Dispos; 2000 Jun; 28(6):664-71. PubMed ID: 10820139
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 reaction phenotyping and inhibition and induction studies of pinostrobin in human liver microsomes and hepatocytes.
Tan S; Dong Z; Zhang J; Efferth T; Fu Y; Hua X
Biomed Chromatogr; 2017 Jun; 31(6):. PubMed ID: 28111763
[TBL] [Abstract][Full Text] [Related]
8. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases.
Jin SE; Seo CS; Shin HK; Ha H
Pharmacogn Mag; 2016; 12(48):241-252. PubMed ID: 27867264
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes.
Pang NH; Xu RA; Chen LG; Chen Z; Hu GX; Zhang BW
Toxicol In Vitro; 2024 Mar; 95():105739. PubMed ID: 38042355
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450.
McCormick A; Swaisland H; Reddy VP; Learoyd M; Scarfe G
Xenobiotica; 2018 Jun; 48(6):555-564. PubMed ID: 28657402
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the inhibition of eight major human cytochrome P450 isozymes by a probe substrate cocktail
Valicherla GR; Mishra A; Lenkalapelly S; Jillela B; Francis FM; Rajagopalan L; Srivastava P
Xenobiotica; 2019 Dec; 49(12):1396-1402. PubMed ID: 30747554
[TBL] [Abstract][Full Text] [Related]
12. Interaction between Changan Granule and its main components in the plasma and CYP450 enzymes.
Liu X; Wang Q; Chen M; Tao J; Wang J; Liu S; Hou J; Li D; Wang R
J Ethnopharmacol; 2023 May; 308():116303. PubMed ID: 36841379
[TBL] [Abstract][Full Text] [Related]
13. In vitro studies investigating the interactions between degarelix, a decapeptide gonadotropin-releasing hormone blocker, and cytochrome P450.
Sonesson A; Rasmussen BB
Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):195-202. PubMed ID: 21496210
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.
Sahi J; Black CB; Hamilton GA; Zheng X; Jolley S; Rose KA; Gilbert D; LeCluyse EL; Sinz MW
Drug Metab Dispos; 2003 Apr; 31(4):439-46. PubMed ID: 12642470
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory Effects of
Seo HJ; Ji SB; Kim SE; Lee GM; Park SY; Wu Z; Jang DS; Liu KH
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33802239
[No Abstract] [Full Text] [Related]
16. Pharmacokinetic profile of dalfampridine extended release: clinical relevance in patients with multiple sclerosis.
Weir S; Torkin R; Henney HR
Curr Med Res Opin; 2013 Dec; 29(12):1627-36. PubMed ID: 23157467
[TBL] [Abstract][Full Text] [Related]
17. Interaction between 3,4‑dichlorophenyl‑propenoyl‑sec.‑butylamine (3,4‑DCPB), an antiepileptic drug, and cytochrome P450 in rat liver microsomes and recombinant human enzymes in vitro.
Cheng HX; Lu YY; Wang X; Ren H; Li Q; Wang SM; Ding Y; Lou YQ; Zhang GL
Eur J Pharm Sci; 2018 Oct; 123():241-248. PubMed ID: 30010032
[TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes.
Rifkind AB; Lee C; Chang TK; Waxman DJ
Arch Biochem Biophys; 1995 Jul; 320(2):380-9. PubMed ID: 7625847
[TBL] [Abstract][Full Text] [Related]
19. AM-2201 Inhibits Multiple Cytochrome P450 and Uridine 5'-Diphospho-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
Kim JH; Kwon SS; Kong TY; Cheong JC; Kim HS; In MK; Lee HS
Molecules; 2017 Mar; 22(3):. PubMed ID: 28287454
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition and induction of human liver cytochrome p450 enzymes by milnacipran.
Paris BL; Ogilvie BW; Scheinkoenig JA; Ndikum-Moffor F; Gibson R; Parkinson A
Drug Metab Dispos; 2009 Oct; 37(10):2045-54. PubMed ID: 19608694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
